American Cancer Society: Cancer facts & figures. 2007, Atlanta, GA: The Society
Google Scholar
Jaenisch R, Bird A: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003, 33 (Suppl): 245-254. 10.1038/ng1089.
Article
CAS
PubMed
Google Scholar
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 1990, 61 (5): 759-767. 10.1016/0092-8674(90)90186-I.
Article
CAS
PubMed
Google Scholar
Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002, 3 (6): 415-428.
CAS
PubMed
Google Scholar
Laird PW: Cancer epigenetics. Hum Mol Genet. 2005, 14 (Spec No 1): R65-76. 10.1093/hmg/ddi113.
Article
CAS
PubMed
Google Scholar
Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet. 2000, 24 (2): 132-138. 10.1038/72785.
Article
CAS
PubMed
Google Scholar
Yan PS, Perry MR, Laux DE, Asare AL, Caldwell CW, Huang TH: CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res. 2000, 6 (4): 1432-1438.
CAS
PubMed
Google Scholar
Zardo G, Tiirikainen MI, Hong C, Misra A, Feuerstein BG, Volik S, Collins CC, Lamborn KR, Bollen A, Pinkel D, et al: Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat Genet. 2002, 32 (3): 453-458. 10.1038/ng1007.
Article
CAS
PubMed
Google Scholar
Shi H, Wei SH, Leu YW, Rahmatpanah F, Liu JC, Yan PS, Nephew KP, Huang TH: Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Cancer Res. 2003, 63 (9): 2164-2171.
CAS
PubMed
Google Scholar
Wei SH, Balch C, Paik HH, Kim YS, Baldwin RL, Liyanarachchi S, Li L, Wang Z, Wan JC, Davuluri RV, et al: Prognostic DNA methylation biomarkers in ovarian cancer. Clin Cancer Res. 2006, 12 (9): 2788-2794. 10.1158/1078-0432.CCR-05-1551.
Article
CAS
PubMed
Google Scholar
Widschwendter M, Jiang G, Woods C, Muller HM, Fiegl H, Goebel G, Marth C, Muller-Holzner E, Zeimet AG, Laird PW, et al: DNA hypomethylation and ovarian cancer biology. Cancer Res. 2004, 64 (13): 4472-4480. 10.1158/0008-5472.CAN-04-0238.
Article
CAS
PubMed
Google Scholar
Kunze E, Wendt M, Schlott T: Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Int J Mol Med. 2006, 18 (4): 547-557.
CAS
PubMed
Google Scholar
Mori T, Martinez SR, O'Day SJ, Morton DL, Umetani N, Kitago M, Tanemura A, Nguyen SL, Tran AN, Wang HJ, et al: Estrogen receptor-alpha methylation predicts melanoma progression. Cancer Res. 2006, 66 (13): 6692-6698. 10.1158/0008-5472.CAN-06-0801.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W: Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer. 2006, 106 (6): 1250-1259. 10.1002/cncr.21754.
Article
CAS
PubMed
Google Scholar
Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Muller SC, von Ruecker A: Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Clin Cancer Res. 2005, 11 (11): 4097-4106. 10.1158/1078-0432.CCR-04-1832.
Article
CAS
PubMed
Google Scholar
Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Kollermann J, Miller K, Schrader M: Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin Cancer Res. 2006, 12 (17): 5040-5046. 10.1158/1078-0432.CCR-06-0144.
Article
CAS
PubMed
Google Scholar
Sambrook J, Russell DW: Molecular cloning: a laboratory manual. 2001, Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 3
Google Scholar
Nouzova M, Holtan N, Oshiro MM, Isett RB, Munoz-Rodriguez JL, List AF, Narro ML, Miller SJ, Merchant NC, Futscher BW: Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. J Pharmacol Exp Ther. 2004, 311 (3): 968-981. 10.1124/jpet.104.072488.
Article
CAS
PubMed
Google Scholar
Finkelstein D, Ewing R, Gollub J, Sterky F, Cherry JM, Somerville S: Microarray data quality analysis: lessons from the AFGC project. Arabidopsis Functional Genomics Consortium. Plant Mol Biol. 2002, 48 (1–2): 119-131. 10.1023/A:1013765922672.
Article
CAS
PubMed
Google Scholar
Groot GS, Kroon AM: Mitochondrial DNA from various organisms does not contain internally methylated cytosine in -CCGG- sequences. Biochim Biophys Acta. 1979, 564 (2): 355-357.
Article
CAS
PubMed
Google Scholar
Simon R, Radmacher MD, Dobbin K, McShane LM: Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst. 2003, 95 (1): 14-18.
Article
CAS
PubMed
Google Scholar
Clark SJ, Harrison J, Paul CL, Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 1994, 22 (15): 2990-2997. 10.1093/nar/22.15.2990.
Article
CAS
PubMed
PubMed Central
Google Scholar
Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW: The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Neoplasia. 2004, 6 (3): 187-194. 10.1593/neo.03292.
Article
CAS
PubMed
PubMed Central
Google Scholar
Antequera F, Bird A: Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA. 1993, 90 (24): 11995-11999. 10.1073/pnas.90.24.11995.
Article
CAS
PubMed
PubMed Central
Google Scholar
Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW: Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res. 2006, 66 (22): 10664-10670. 10.1158/0008-5472.CAN-06-2761.
Article
CAS
PubMed
Google Scholar
Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR: Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 2006, 66 (3): 1354-1362. 10.1158/0008-5472.CAN-05-3694.
Article
CAS
PubMed
Google Scholar
Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancers. Nature. 1997, 386 (6625): 623-627. 10.1038/386623a0.
Article
CAS
PubMed
Google Scholar
Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R: DNA hypomethylation leads to elevated mutation rates. Nature. 1998, 395 (6697): 89-93. 10.1038/25779.
Article
CAS
PubMed
Google Scholar
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, et al: Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res. 2008, 14 (4): 1065-1072. 10.1158/1078-0432.CCR-07-1569.
Article
CAS
PubMed
Google Scholar
Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA, Goodman SN, David KA, Juhl H, et al: Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA. 2005, 102 (45): 16368-16373. 10.1073/pnas.0507904102.
Article
CAS
PubMed
PubMed Central
Google Scholar